ATA903489A - Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren - Google Patents

Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren

Info

Publication number
ATA903489A
ATA903489A AT0903489A AT903489A ATA903489A AT A903489 A ATA903489 A AT A903489A AT 0903489 A AT0903489 A AT 0903489A AT 903489 A AT903489 A AT 903489A AT A903489 A ATA903489 A AT A903489A
Authority
AT
Austria
Prior art keywords
tumors
compositions
detection
treatment
protoporphyrinogen
Prior art date
Application number
AT0903489A
Other languages
English (en)
Other versions
AT400520B (de
Inventor
Blaik Phillip Halling
Debra Ann Witkowski
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of ATA903489A publication Critical patent/ATA903489A/de
Application granted granted Critical
Publication of AT400520B publication Critical patent/AT400520B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT0903489A 1988-12-12 1989-12-08 Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren AT400520B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03

Publications (2)

Publication Number Publication Date
ATA903489A true ATA903489A (de) 1995-06-15
AT400520B AT400520B (de) 1996-01-25

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0903489A AT400520B (de) 1988-12-12 1989-12-08 Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren

Country Status (28)

Country Link
EP (1) EP0447491B1 (de)
JP (1) JP2545000B2 (de)
KR (1) KR930003116B1 (de)
AR (1) AR243605A1 (de)
AT (1) AT400520B (de)
AU (1) AU633537B2 (de)
BR (1) BR8907817A (de)
CA (1) CA2004979A1 (de)
CH (1) CH681779A5 (de)
DE (2) DE3991484T (de)
DK (1) DK110791A (de)
EG (1) EG18822A (de)
ES (1) ES2051675T3 (de)
FI (1) FI912784A0 (de)
GB (1) GB2247404B (de)
GR (1) GR1000609B (de)
HU (1) HUT58202A (de)
IE (1) IE62621B1 (de)
IL (1) IL92622A (de)
LU (1) LU87949A1 (de)
LV (1) LV10303B (de)
MC (1) MC2171A1 (de)
NO (1) NO912228D0 (de)
NZ (1) NZ231658A (de)
OA (1) OA09362A (de)
PT (1) PT92546B (de)
SE (1) SE505938C2 (de)
WO (1) WO1990006748A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6084155A (en) 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
HUP9901044A3 (en) * 1996-02-28 2001-11-28 Syngenta Participations Ag Dna molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
DK2443102T3 (da) 2009-06-19 2013-07-08 Basf Se Herbicidale benzoxazinoner
EP2496573B1 (de) * 2009-11-02 2015-07-01 Basf Se Herbizide tetrahydrophthalimide
JP2013540113A (ja) 2010-10-01 2013-10-31 ビーエーエスエフ ソシエタス・ヨーロピア 除草性ベンゾオキサジノン
WO2012080239A1 (en) 2010-12-15 2012-06-21 Basf Se Herbicidal compositions
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
BR112019010732B1 (pt) * 2016-12-16 2023-01-31 Basf Se Feniltriazolinonas, processo para a preparação de feniltriazolinonas, composições herbicidas, processo para a preparação de composições ativas de herbicida, método para controlar vegetação indesejada e uso das feniltriazolinonas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides

Also Published As

Publication number Publication date
GB2247404B (en) 1993-03-03
GB9110472D0 (en) 1991-11-27
IL92622A0 (en) 1990-08-31
PT92546B (pt) 1995-09-12
WO1990006748A2 (en) 1990-06-28
EP0447491B1 (de) 1993-08-11
DE3991484C2 (de) 1995-02-23
AU633537B2 (en) 1993-02-04
NO912228L (no) 1991-06-11
WO1990006748A3 (en) 1990-10-04
ES2051675T3 (es) 1994-11-01
JPH04501420A (ja) 1992-03-12
PT92546A (pt) 1990-06-29
IL92622A (en) 1996-05-14
LV10303B (en) 1995-08-20
FI912784A7 (fi) 1991-06-10
DK110791D0 (da) 1991-06-11
GR1000609B (el) 1992-08-31
AU4822290A (en) 1990-07-10
EG18822A (en) 1994-09-29
KR930003116B1 (ko) 1993-04-19
SE9101807L (sv) 1991-06-12
MC2171A1 (fr) 1992-05-22
AR243605A1 (es) 1993-08-31
NZ231658A (en) 1992-05-26
CA2004979A1 (en) 1990-06-12
IE62621B1 (en) 1995-02-22
KR910700046A (ko) 1991-03-13
JP2545000B2 (ja) 1996-10-16
ES2051675T1 (es) 1994-07-01
GR890100817A (en) 1991-03-15
DE3991484T (de) 1991-11-21
IE893925L (en) 1990-06-12
DK110791A (da) 1991-08-12
BR8907817A (pt) 1991-10-22
FI912784A0 (fi) 1991-06-10
HUT58202A (en) 1992-02-28
SE505938C2 (sv) 1997-10-27
LV10303A (lv) 1994-10-20
SE9101807D0 (sv) 1991-06-12
EP0447491A1 (de) 1991-09-25
GB2247404A (en) 1992-03-04
OA09362A (en) 1992-09-15
NO912228D0 (no) 1991-06-11
AT400520B (de) 1996-01-25
LU87949A1 (fr) 1991-12-16
CH681779A5 (de) 1993-05-28

Similar Documents

Publication Publication Date Title
DE69622074D1 (de) Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE68926248D1 (de) p100 "neu" menschlisches Protein and Verwendung dieses Proteins zum Nachweis von preneoplasmatischen- oder neoplasmatischen beim Menschen
FI904254A7 (fi) Menetelmät ja koostumukset patologisten hydrofobisten vaikutusten käsi ttelemiseksi biologisissa nesteissä
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DE69312624D1 (de) Vorrichtung zur unterscheidung von tachykardien und fibrillationen und zur entsprechenden behandlung
DE69219819D1 (de) Anlage zur Behandlung von Oberflächenwasser mit Rückhaltesicherung, Rückhaltesicherung, und deren Verwendung
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69224080D1 (de) Verwendung von nsaid zur behandlung von demenz
DE3855715D1 (de) Verfahren und Zusammensetzung zum Nachweis von Chlorid-Ionen in Flüssigkeiten
DE69101922D1 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
DE69018457D1 (de) Gegenstände zur behandlung von periodontitis und knochendefekten.
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DE59310276D1 (de) Verwendung von Polyasparaginsäure und ihrer Salze
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69506154D1 (de) Zusammensetzugen enthaltend amphotere Salze von Alpha-Hydroxysäuren und Glycerinmonocaprylat
DE69316203D1 (de) Elektrochemische behandlung von oberflächen
DE69422842D1 (de) Verfahren und Einrichtung zur Behandlung von Lithium
KR880700673A (ko) 골손상 치료용방법 및 조성물
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
ATE204177T1 (de) Verwendung von substanz p antagonist im pharmazeutischer zusammensetzung
DE58901593D1 (de) Verfahren und einrichtung zur thermischen behandlung von abfallstoffen.
FI921746A7 (fi) Aineita ja menetelmiä vieraan kudoksen käsittelemiseksi
DE3669886D1 (de) Produkte und verfahren zum behandeln von geweben.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee